Equity (finance)

US Heart & Vascular Expands to Kansas through Partnership with Heartland Cardiology

Retrieved on: 
Thursday, April 27, 2023

US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announced its partnership with Heartland Cardiology (“Heartland”), a Wichita-based cardiovascular physician practice focused on preventative care, diagnostic testing, curative procedures and electrophysiology services.

Key Points: 
  • US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announced its partnership with Heartland Cardiology (“Heartland”), a Wichita-based cardiovascular physician practice focused on preventative care, diagnostic testing, curative procedures and electrophysiology services.
  • With an expanding network of practices in Arizona, Texas, and Kansas, USHV is actively seeking new partners with quality practices and entrepreneurial cardiovascular physicians across the country.
  • “We are very excited about our partnership with USHV, which will enable Heartland Cardiology to remain independent, innovative, progressive, and most importantly empower us to continue our mission as promised since 1994 – providing the most compassionate care for Kansas hearts,” said Wassim Shaheen, M.D.
  • In addition, we will remain a physician-owned practice, collaborating with our partner colleagues and primary care physicians throughout the state of Kansas.

US Heart & Vascular Announces Partnership with HeartPlace, one of the Largest Cardiovascular Groups in the United States

Retrieved on: 
Thursday, April 20, 2023

US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, has partnered with HeartPlace (“HeartPlace”), the largest physician-owned cardiology practice in Texas, focused on all aspects of cardiovascular care.

Key Points: 
  • US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, has partnered with HeartPlace (“HeartPlace”), the largest physician-owned cardiology practice in Texas, focused on all aspects of cardiovascular care.
  • “We are thrilled to welcome HeartPlace, the premier independent cardiovascular practice in Texas, to the USHV family.
  • US Heart and Vascular continues to support patient-centric, physician-led practices that are dedicated to delivering exceptional patient outcomes,” said Chris Krubert, M.D., Executive Chairman of USHV.
  • We look forward to expanding our reach beyond North Texas and working together to improve cardiovascular health outcomes for our patients,” Rick continued.

Prairie Provident Resources Announces Amendments to Recapitalization Transactions that Significantly Enhance Value to Shareholders

Retrieved on: 
Tuesday, April 11, 2023

CALGARY, Alberta, April 11, 2023 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. (TSX: PPR) ("Prairie Provident" or the "Company") announces amendments to the terms of the equity financing and debt settlement components of its previously announced recapitalization transactions (collectively, the "Recapitalization").

Key Points: 
  • Completion of the Equity Financing and the Subordinated Notes Conversion is subject to receipt of all necessary approvals of the TSX.
  • In this regard, Prairie Provident has applied to the TSX for an exemption from shareholder approval requirements under TSX rules, pursuant to the 'financial hardship' provisions of the TSX Company Manual.
  • The TSX is considering the 'financial hardship' application in connection with its review of the Company's request for TSX approval of the applicable Recapitalization transactions.
  • There is no certainty that the TSX will approve such transactions, or accept the Company's application to rely on the financial hardship exemption.

Prairie Provident Resources Announces Fourth Quarter and Year-End 2022 Financial and Operating Results and Update on Repositioning Plan

Retrieved on: 
Saturday, April 1, 2023

CALGARY, Alberta, April 01, 2023 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident", "PPR" or the "Company") announces our operating and financial results for the fourth quarter and year ended 2022.

Key Points: 
  • CALGARY, Alberta, April 01, 2023 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident", "PPR" or the "Company") announces our operating and financial results for the fourth quarter and year ended 2022.
  • Although the Company achieved production only slightly (6%) below previously guided volumes, 2022 saw headwinds for Prairie Provident, primarily through $25.5 million of realized hedging losses from mandatory credit facility hedging requirements.
  • Earlier this week PPR announced a comprehensive recapitalization plan to significantly improve the Company's financial flexibility and sustainability (detailed below).
  • From an improved financial position from the recapitalization explore transactions that may unlock value within the Company.

Morrison Foerster Continues Expansion of Private Equity Capabilities in Asia with Addition of Rongjing Zhao

Retrieved on: 
Tuesday, April 4, 2023

LONDON, April 3, 2023 /PRNewswire-PRWeb/ -- Morrison Foerster, a leading global law firm, is pleased to announce the arrival of Rongjing Zhao, as a partner in the firm's Private Equity and Mergers & Acquisitions Groups, based out of its China offices. Zhao brings to Morrison Foerster more than 15 years of experience representing private equity firms, as well as public and private companies, in a variety of complex cross-border transactions. Zhao's addition underscores the continued expansion of the firm's leading private equity capabilities in Asia, where Morrison Foerster is ranked in Band 1 for Private Equity in the latest edition of Chambers Asia-Pacific and Tier 1 for China: Private Equity in The Legal 500 Asia Pacific 2021-2023, and across the firm's global offices. She is the fourth private equity partner to join the firm this quarter, following the additions of Steven Tran and Tabitha Saw in Singapore, and James Beach in San Francisco.

Key Points: 
  • Zhao's addition further strengthens and deepens the firm's global private equity capabilities in China, Asia, and beyond; fourth private equity partner to join since the start of 2023
    LONDON, April 3, 2023 /PRNewswire-PRWeb/ -- Morrison Foerster, a leading global law firm, is pleased to announce the arrival of Rongjing Zhao , as a partner in the firm's Private Equity and Mergers & Acquisitions Groups, based out of its China offices.
  • Zhao brings to Morrison Foerster more than 15 years of experience representing private equity firms, as well as public and private companies, in a variety of complex cross-border transactions.
  • Zhao's addition underscores the continued expansion of the firm's leading private equity capabilities in Asia, where Morrison Foerster is ranked in Band 1 for Private Equity in the latest edition of Chambers Asia-Pacific and Tier 1 for China: Private Equity in The Legal 500 Asia Pacific 2021-2023, and across the firm's global offices.
  • "Rongjing is a highly sophisticated, U.S.-trained lawyer and Mandarin native speaker with extensive private equity M&A experience in China, Asia, and the U.S.," said Marcia Ellis, global co-chair of Morrison Foerster's Private Equity Group.

Prairie Provident Resources Announces Transformative Recapitalization Transactions

Retrieved on: 
Wednesday, March 29, 2023

Going forward, completion of the Recapitalization is expected to provide Prairie Provident with a sustainable capital structure and the capital resources necessary to optimize its current producing assets as well as develop its currently undeveloped land base, for the benefit of all stakeholders.

Key Points: 
  • Going forward, completion of the Recapitalization is expected to provide Prairie Provident with a sustainable capital structure and the capital resources necessary to optimize its current producing assets as well as develop its currently undeveloped land base, for the benefit of all stakeholders.
  • In recent years, Prairie Provident has faced an increasingly challenging lack of liquidity and deteriorating capital resource position.
  • Prairie Provident intends to close the Equity Financing as soon as possible in order to address its near-term working capital needs.
  • As the Noteholder will, after giving effect to the Subordinated Notes Conversion, Warrant Exercise and Equity Financing, hold more than 80% of the outstanding Common Shares after the Recapitalization, the Noteholder will be a 'control person' of Prairie Provident under applicable Canadian securities laws, and the Recapitalization will materially affect control of Prairie Provident within the meaning of TSX rules.

Innovative Industrial Properties Announces Senior Leadership Appointment and Promotions

Retrieved on: 
Wednesday, March 29, 2023

Mr. Smith held the same roles at Treehouse, a privately-held REIT focused on the regulated cannabis industry, from October 2019 through December 2020.

Key Points: 
  • Mr. Smith held the same roles at Treehouse, a privately-held REIT focused on the regulated cannabis industry, from October 2019 through December 2020.
  • Prior to Treehouse, Mr. Smith served as the Executive Vice President and Chief Financial Officer of New Senior Investment Group Inc. (NYSE: SNR) from January 2019 to September 2019.
  • Mr. Smith received a Bachelor of Science degree with honors in Finance from the University of Wisconsin-La Crosse.
  • “I am delighted to welcome David to our senior management team,” commented Paul Smithers, IIP’s President and Chief Executive Officer.

Nevada Lithium and Iconic Minerals Enter into Arrangement Agreement to Consolidate 100% Ownership Interest In the Bonnie Claire Lithium Property, Nevada

Retrieved on: 
Monday, March 27, 2023

After the closing of the Arrangement, Nevada Lithium will hold a 100% interest in the Project.

Key Points: 
  • After the closing of the Arrangement, Nevada Lithium will hold a 100% interest in the Project.
  • Stephen Rentschler, Nevada Lithium's CEO, commented, "We are pleased to announce the signing of the Arrangement Agreement with Iconic for the Bonnie Claire Project.
  • The Arrangement Agreement also provides for a payment of a termination fee of $500,000 payable by Iconic or Nevada Lithium to the other in certain circumstances.
  • Upon completion of the Arrangement, each Nevada Lithium FinCo Share and each Nevada Lithium FinCo Warrant will be exchanged on a one-for-one basis for, respectively, Nevada Lithium Shares and Nevada Lithium Warrants.

VERSES Announces Convertible Debenture Financing of up to C$5,000,000

Retrieved on: 
Monday, February 27, 2023

Each Convertible Debenture will mature on the date that is 12 months from the date of issuance of the Convertible Debenture (the “Maturity Date”).

Key Points: 
  • Each Convertible Debenture will mature on the date that is 12 months from the date of issuance of the Convertible Debenture (the “Maturity Date”).
  • On the Maturity Date, the outstanding principal amount of the Convertible Debentures (the “Principal Amount”) shall be repaid in cash.
  • For the purposes of this news release, “Equity Securities” means Shares of the Company or any securities convertible into or exercisable or exchangeable for Shares.
  • Each Convertible Debenture shall rank subordinate to all secured debt obligations of the Company.

Tonix Pharmaceuticals Announces New Board Member, R. Newcomb Stillwell

Retrieved on: 
Thursday, February 23, 2023

CHATHAM, N.J., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the appointment of R. Newcomb Stillwell to its Board of Directors, to be effective as of March 15, 2023.

Key Points: 
  • CHATHAM, N.J., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the appointment of R. Newcomb Stillwell to its Board of Directors, to be effective as of March 15, 2023.
  • “We are pleased to welcome Newcomb to our Board of Directors," said Seth Lederman, M.D., President and Chief Executive Officer of Tonix.
  • Mr. Stillwell received a J.D., cum laude, from Harvard Law School and an A.B., magna cum laude, from Princeton University.
  • Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics to treat and prevent human disease and alleviate suffering.